Patricia Rich

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Melissa L. Johnson, Zanete Zvirbule, Åslaug Helland et al. · Journal of Thoracic Oncology · 2021 · 147 citations · Full text

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort

Benjamin Tan, Adnan Khattak, Enriqueta Felip et al. · Targeted Oncology · 2021 · 41 citations · Full text

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Tareq Al Baghdadi, Elizabeth Garrett‐Mayer, Susan Halabi et al. · Targeted Oncology · 2020 · 40 citations

Gastrointestinal Oncology, Medicine, Pharmacology +9

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

David R. Spigel, Afshin Dowlati, Yuanbin Chen et al. · Journal of Clinical Oncology · 2024 · 29 citations · Full text

Comparison of two PEG‐interferon alpha‐2b doses (1.0 or 1.5 <i>μ</i>g/kg) combined with ribavirin in interferon‐naïve patients with chronic hepatitis C and up to moderate fibrosis

B Meyer-Wyss, Patricia Rich, Hp Egger et al. · Journal of Viral Hepatitis · 2006 · 26 citations